Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T89176
|
|||||
Target Name |
Clostridium difficile DNA gyrase (CD gyr)
|
|||||
Gene Name |
CD gyrA; CD gyrB
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Clostridium difficile enterocolitis [ICD-11: 1A04] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 1 Clinical Trial Drugs | + | ||||
1 | DS-2969 | Drug Info | Phase 1 | Clostridium infection | [1] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Inhibitor | [+] 1 Inhibitor drugs | + | ||||
1 | DS-2969 | Drug Info | [1] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | In Vitro and In Vivo Activities of DS-2969b, a Novel GyrB Inhibitor, against Clostridium difficile. Antimicrob Agents Chemother. 2018 Mar 27;62(4):e02157-17. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.